These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 18992649)

  • 1. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
    J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung E; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2007 Jan; 49(1):50-8. PubMed ID: 17207722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of microvolt T-wave alternans to predict outcomes in patients with ischemic cardiomyopathy beyond one year.
    Chan PS; Kereiakes DJ; Bartone C; Chow T
    Am J Cardiol; 2008 Aug; 102(3):280-4. PubMed ID: 18638586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.
    Chow T; Saghir S; Bartone C; Goebel M; Schneider J; Booth T; Chan PS
    Am J Cardiol; 2007 Aug; 100(4):598-604. PubMed ID: 17697813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
    Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
    Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
    Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
    Bloomfield DM; Bigger JT; Steinman RC; Namerow PB; Parides MK; Curtis AB; Kaufman ES; Davidenko JM; Shinn TS; Fontaine JM
    J Am Coll Cardiol; 2006 Jan; 47(2):456-63. PubMed ID: 16412877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?
    Armoundas AA; Hohnloser SH; Ikeda T; Cohen RJ
    Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):522-8. PubMed ID: 16186850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
    Wierzbowski R; Michałkiewicz D; Cholewa M; Jacewicz K; Gniłka A; Adamus J
    Pol Merkur Lekarski; 2006 Oct; 21(124):310-3. PubMed ID: 17205766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis.
    Gupta A; Hoang DD; Karliner L; Tice JA; Heidenreich P; Wang PJ; Turakhia MP
    Am Heart J; 2012 Mar; 163(3):354-64. PubMed ID: 22424005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal.
    Chan PS; Bartone C; Booth T; Kereiakes D; Chow T
    Am Heart J; 2007 Apr; 153(4):523-9. PubMed ID: 17383288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate ventricular tachycardia after abnormal microvolt T-wave alternans.
    Sedkowska A; Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Kalarus Z
    Cardiol J; 2009; 16(4):365-7. PubMed ID: 19653182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing specificity without sacrificing sensitivity: potential benefits of using microvolt T-wave alternans testing to risk stratify the MADIT-II population.
    Cohen RJ
    Card Electrophysiol Rev; 2003 Dec; 7(4):438-42. PubMed ID: 15071271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis.
    Gehi AK; Stein RH; Metz LD; Gomes JA
    J Am Coll Cardiol; 2005 Jul; 46(1):75-82. PubMed ID: 15992639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The problem of indeterminate microvolt T-wave alternans results in patients with left ventricular dysfunction referred for implantable cardioverter-defibrillator implantation in the primary prevention of sudden cardiac death.
    Daniłowicz Szymanowicz L; Szwoch M; Kempa M; Raczak G
    Kardiol Pol; 2012; 70(8):795-802. PubMed ID: 22933211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
    Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH
    Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.